Every record from Janoshik · page 8
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042597 | Tirzepatide | GGPeps | GGPE-2604-H8313 | 2026-Q2 | 99.31 | 2.01 | 90.7 | Supplier-supplied | 0 | PASS |
| AX-2026-041957 | BPC-157 | TFC | TFC-2511-S4569 | 2026-Q2 | 99.92 | 5.00 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041819 | PT-141 (Bremelanotide) | FGP | FGP-2602-Y1702 | 2026-Q2 | 99.93 | 4.19 | 93.0 | Supplier-supplied | 0 | PASS |
| AX-2026-041448 | Liraglutide | QYB | QYB-2511-V5143 | 2026-Q2 | 99.54 | 5.58 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043245 | Melanotan II | SGN | SGN-2602-L1809 | 2026-Q2 | 98.54 | 2.19 | 100.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043244 | Melanotan II | SGN | SGN-2602-L1809 | 2026-Q2 | 99.24 | 2.68 | 98.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043205 | GHK-Cu | SGN | SGN-2603-X9044 | 2026-Q2 | 97.53 | 4.68 | 98.0 | Supplier-supplied | 0 | PASS |
| AX-2026-043076 | Tirzepatide | KP | KP-2605-E6030 | 2026-Q2 | 97.68 | 3.59 | 104.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042903 | Semax | MKM | MKM-2512-B2992 | 2026-Q2 | 98.61 | 6.89 | 99.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042862 | Retatrutide | GGPeps | GGPE-2601-C2423 | 2026-Q2 | 98.09 | 4.22 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042636 | IGF-1 LR3 | GGPeps | GGPE-2604-K8140 | 2026-Q2 | 98.39 | 2.26 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042159 | GHRP-2 | Homopeptide | HOMO-2602-E9033 | 2026-Q2 | 99.39 | 3.77 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041396 | Adipotide | WWB | WWB-2512-R4093 | 2026-Q2 | 98.96 | 3.00 | 94.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043257 | BPC-157 | SGN | SGN-2512-H1950 | 2026-Q2 | 98.34 | 4.94 | 101.3 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042867 | BPC-157 | GGPeps | GGPE-2512-G2285 | 2026-Q2 | 98.82 | 3.05 | 98.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042642 | IGF-1 LR3 | GGPeps | GGPE-2604-K8140 | 2026-Q2 | 98.18 | 2.54 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041839 | Tirzepatide | JEEP | JEEP-2602-J2798 | 2026-Q2 | 98.38 | 4.31 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041269 | Semaglutide | WWB | WWB-2603-W2120 | 2026-Q2 | 99.45 | 4.07 | 89.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043460 | BPC-157 | WXT | WXT-2602-W4680 | 2026-Q2 | 98.38 | 5.11 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042995 | TB-500 | KP | KP-2605-C4659 | 2026-Q2 | 98.99 | 5.49 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042562 | Mazdutide | ERP | ERP-2603-D7882 | 2026-Q2 | 97.46 | 4.39 | 102.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042115 | PT-141 (Bremelanotide) | TFC | TFC-2512-M8211 | 2026-Q2 | 99.19 | 7.08 | 103.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042105 | Retatrutide | TFC | TFC-2512-G7985 | 2026-Q2 | 98.41 | 1.88 | 105.2 | Supplier-supplied | 0 | PASS |
| AX-2026-041250 | GHK-Cu | WWB | WWB-2512-B1996 | 2026-Q2 | 99.43 | 6.14 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042591 | Tirzepatide | GGPeps | GGPE-2604-H8313 | 2026-Q2 | 99.33 | 1.36 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042589 | SLU-PP-332 | GGPeps | GGPE-2511-R8569 | 2026-Q2 | 98.75 | 4.28 | 90.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042156 | Tirzepatide | Homopeptide | HOMO-2601-N9196 | 2026-Q2 | 98.07 | 5.83 | 103.3 | Buyer-sourced | 1 | MARGINAL |
| AX-2026-041288 | Semaglutide | WWB | WWB-2603-N3120 | 2026-Q2 | 99.45 | 6.16 | 90.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042429 | IGF-1 DES (1-3) | SWB | SWB-2601-Y5870 | 2026-Q2 | 98.11 | 4.09 | 97.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041658 | Semaglutide | QSC | QSC-2511-M9226 | 2026-Q2 | 99.60 | 3.73 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043442 | Semaglutide | WXT | WXT-2512-F4804 | 2026-Q2 | 98.54 | 5.41 | — | Laboratory-retained | 2 | MARGINAL |
| AX-2026-043443 | Semaglutide | WXT | WXT-2512-F4804 | 2026-Q2 | 98.28 | 4.80 | 91.9 | Laboratory-retained | 2 | MARGINAL |
| AX-2026-042655 | Semax | GGPeps | GGPE-2602-Y8213 | 2026-Q2 | 99.09 | 5.09 | 106.4 | Supplier-supplied | 0 | PASS |
| AX-2026-042424 | CJC-1295 with DAC | SWB | SWB-2511-Y5187 | 2026-Q2 | 98.72 | 4.15 | 103.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042337 | L-Glutathione (reduced) | HJ | HJ-2511-F3082 | 2026-Q2 | 99.93 | 7.58 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041502 | Kisspeptin-10 | QYB | QYB-2512-X5662 | 2026-Q2 | 99.93 | 4.03 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041466 | SS-31 (Elamipretide) | QYB | QYB-2512-H5402 | 2026-Q2 | 99.93 | 5.07 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041268 | Semaglutide | WWB | WWB-2603-W2120 | 2026-Q2 | 99.76 | 3.52 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043560 | GHRP-6 | BCH | BCH-2603-Y7018 | 2026-Q2 | 99.25 | 5.25 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043134 | BPC-157 | SSA | SSA-2601-N6752 | 2026-Q2 | 98.39 | 4.76 | — | Supplier-supplied | 1 | MARGINAL |